Benoit Chabot
Researcher from Université de Sherbrooke discussing anticancer potential of CLK kinase inhibitors
Best podcasts with Benoit Chabot
Ranked by the Snipd community
May 29, 2024 • 7min
Behind the Study: Anticancer Potential of CLK Kinase Inhibitors 1C8 and GPS167
Dr. Benoit Chabot discusses the anticancer potential of CLK kinase inhibitors 1C8 and GPS167, impacting cell proliferation and gene expression. The compounds influence pathways like MIC targets, TGF beta signaling, and splicing mechanisms, potentially affecting metastasis and antiviral immune response.
